CARB-X Grant for Preclinical Programs
In the lead up to its capital markets day, Basilea Pharmaceutica announced it has received initial funding of up to US$0.9m through a...
CARB-X Grant for Preclinical Programs
Positive Signals Abound
Zevtera Crosses Key US Regulatory Hurdle
Onwards and Upwards with Strong FY23
From Strength to Strength
Antibiotic addition to further replenish pipeline
Growth Pivot with Potential Antibacterial Addition
FDA Accepts New Drug Application for Ceftobiprole
Differentiating Immunotherapy Truths vs Opinion
Prompt Receipt of Milestone Payments for Cresemba
Zevtera NDA Submission Pushed to Q323
Solid FY22 Marked by Broad-Based Growth